Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project.
Devgun JM, Zhang R, Brent J, Wax P, Burkhart K, Meyn A, Campleman S, Abston S, Aldy K. Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project. JAMA Netw Open. 2023 02 01; 6(2):e2255815.